APOAT - ARCSA Registration f8b8fbff6d521b3b2d0a68c24ed0f8e3
Access comprehensive regulatory information for APOAT in the Ecuador medical device market through Pure Global AI's free database. This II medical device is registered under ARCSA ID f8b8fbff6d521b3b2d0a68c24ed0f8e3 and manufactured by ROCHE DIAGNOSTICS GMBH. The device was registered on October 31, 2023.
This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.
Free Database
Powered by Pure Global AI
ARCSA Official Data
II
f8b8fbff6d521b3b2d0a68c24ed0f8e3
APOAT
ARCSA ID: f8b8fbff6d521b3b2d0a68c24ed0f8e3
Device Classification
Risk Class
II
Product Type
In Vitro Diagnostic
Brand Name
ROCHE
Commercial Name
18-900 Reagents/Kits for IVD, Clinical Chemistry, Protein Assays
Registration Information
Analysis ID
f8b8fbff6d521b3b2d0a68c24ed0f8e3
Registration Date
October 31, 2023
Expiration Date
October 31, 2028
Product Use
QUANTITATIVE DETERMINATION OF APOLIPOPROTEIN A-1 IN HUMAN SERUM AND PLASMA.
Manufacturer
Product Owner
Name
ROCHE DIAGNOSTICS GMBH
Country
GERMANY
Authorized Representative